A case of immune-mediated encephalitis related to daclizumab therapyMultiple Sclerosis Journal, Ahead of Print. … read morePosted At: MS Journal
Inclusion criteria used in trials of people with progressive multiple sclerosisMultiple Sclerosis Journal, Ahead of Print. … read morePosted At: MS Journal
Trait neuroticism, extraversion, and conscientiousness in multiple sclerosis: Link to cognitive impairment?
Trait neuroticism, extraversion, and conscientiousness in multiple sclerosis: Link to cognitive impairment?Multiple Sclerosis Journal, Ahead of Print. … read morePosted At: MS Journal
Study Shows Therapeutic Horseback Riding (Hippotherapy) Improves Balance and More in People with MS/About-the-Society/News/Study-Shows-Therapeutic-Horseback-Riding-(Hippothe … read morePosted At: National MS Society
Enhancing natural killer cells is beneficial in multiple sclerosis – YesMultiple Sclerosis Journal, Ahead of Print. … read morePosted At: MS Journal
- Next story Primary progressive multiple sclerosis presenting with severe predominant cognitive impairment and psychiatric symptoms: A challenging case
- Previous story Secondary paroxysmal dyskinesia in multiple sclerosis: Clinical–radiological features and treatment. Case report of seven patients
Join Our Mailing List
- Retinal degeneration is associated with brain volume reduction and prognosis in radiologically isolated syndrome
- False hepatitis B and C viral serologies in patients with multiple sclerosis receiving high-dose biotin
- What to know about marijuana and multiple sclerosis
- Using graphene to detect ALS, other neurodegenerative diseasesPosted At: Science Daily
- Is the ketogenic diet good for multiple sclerosis?
- What is Lhermitte’s sign?
- What to know about multiple sclerosis and mood swings
- FDA Issues Warning About Rare Risk of Stroke and Artery Wall Tears with Use of Lemtrada Posted At: National MS Society
- Pregnancy and multiple sclerosis in the DMT era: A cohort study in Western Austria
- Fatigue at enrollment predicts EDSS worsening in the New York State Multiple Sclerosis Consortium